Eric Dane

Company: AstraZeneca Pharmaceuticals, Research & Development

Job title: Associate Principal Scientist

Seminars:

Unlocking Targeted Non-Viral Delivery Methods for RNA-Based Gene Editing Payloads to Minimize Toxic Effects for Improved Therapies 1:05 pm

Gene editing payloads contain both the editor and guide RNA, making them much more complex to package. Similarly, there is potential for toxic side effects of permanent off target editing, and such it is vital that drug developers employ cell specific delivery vehicles. Uncover the key principles for successful delivery of RNAbased gene editors to…Read more

day: Pre-Conference Day